Debra Patt, MD, MPH, MBA, VP of Texas Oncology discusses the importance of patrolling drug costs and reimbursements for Texas Oncology at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Advertisement
How do you see the new administration addressing drug costs?
